Neurology 1212 - Neurology Alert - Dec 01, 2008

Target Audience:

This activity is intended for the neurologist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Physician Editor
Matthew Fink, MD
Vice Chairman, Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork Presbyterian Hospital

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman,
Department of Neurology and Neuroscience

Assistant Editors
Claire Henchcliffe, MD, DPhil
Assistant Professor of Neurology and Neuroscience
Specialty area, Movement Disorders

John J. Caronna, MD
Professor of Clinical Neurology
Specialty area, Stroke and General Neurology

Michael Rubin, MD FRCP(C)
Professor of Clinical Neurology
Weill Medical College of Cornell University
NewYork Presbyterian Hospital

Norman Latov, MD, PhD
Professor of Neurology and Neuroscience,
Director of the Peripheral Neuropathy Center
Weill Medical College
Cornell University

Melissa J. Nirenberg, MD, PhD
Assistant Professor, Neurology and Neuroscience
Weill Cornell Medical College


  • Painful Legs and Moving Toes: How to Diagnose and What to Do?
  • IV Valproic Acid vs Phenytoin: Old Standby or the New Challenger?
  • Carotid Arterial Dissection: Time for a Randomized Clinical Trial
  • A Neurophysiology Study: Thalidomide and Sensory Neurotoxicity
  • Needle Electromyography: Hemorrhagic Risks and Complications
  • Anxiety in Parkinson's Disease: Diagnostic Evaluation and Pitfalls


  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert's physician editor, Matthew Fink, MD, reports no consultant, stockholder, speaker’s bureau, research, or other relationships related to this field of study. Peer reviewer M. Flint Beal, MD, reports no consultant, stockholder, speaker’s bureau, research, or other financial relationship with any company having ties to this field of study. Assistant editor Claire Henchcliffe, MD serves on the speaker's bureau for GlaxoSmithKline, Teva, Boehringer Ingelheim, Schwarz Pharma, and Allergan. Assistant editor Michael Rubin, MD, FRCP(C) reports that he receives grant/research support from Pfizer and that he is on the speaker's bureau for Athena Diagnostics. Assistant editors John J. Caronna, MD, report no financial relationships relevant to this field of study. Author Norman Latov, MD, PhD received grants/research support from Talecris Biopharmaceuticals, is a stockholder in Therapath LLC, is a retained consultant for Quest Diagnostics, and received royalty payments from Athena Diagnostics. Author Melissa J. Nirenberg, MD, PhD has consulted for Biovail and participated in clinical trials sponsored by Boehringer-Ingelheim.

Copyright 2008 AHC Media. All rights reserved.